Does your organization have standardized mitigation strategies in the OR when a patient has a history of malignant hyperthermia?

Our anesthesia group currently does not have a standard so there is some variability in practice. Typically they will move succhinylcholine from the main drawer, or put tape over the pocket in the ADC with a note indicating MH patient. Different individuals may do more or less. I'd like to look towards standardization. Curious what others do!

Thanks,
Sloane Hoefer
Nebraska Medicine

Hello!

Curious what other pediatric institutions do in regards to preparation/dispensing and administration of hyaluronidase for extravasations in the pediatric population!

1. Straight drug (150 units/mL) or dilution (15 units/mL) for administration?
2. If dilution
a) who prepares: pharmacy or nursing?
b) all pediatric patients or just neonates/small infants?
c) if you have Epic, how is your order built out?

Thanks in advance!
Rachael Schortemeyer

How are systems handling the transition away from Levemir, particularly with home medications being continued in house and upon discharge if patient still have supply at home? Trying to deter in-patient continuation and discharge on this medication. Thanks in advance!

For pediatric patients, Is anyone using pre-mixed tranexamic acid bags (instead of vials) for anesthesia/OR use to prevent the possibility of intrathecal administration? If yes, have you had any issues with fluid overload (pre-mixed bag more dilute 10 mg/mL)? Thank you! -Nick

Do you have any policies or SOPs that you would be willing to share if your hospital allows bulk items (inhalers, insulin pens, ointments, creams, etc.) to relabeled at discharge to send home with the patient.

Sondra May
Children's Hospital Colorado

Our organization utilizes Baxter Spectrum IQ pumps and have had some of issues with TPNs running dry faster than expected. Initial biomed reports are finding that they may be running faster than the typical 5% variance/allowance. Anyone else experiencing anything similar?

We have gotten several reports lately from nursing of a failure of the hanger attached to the propofol vials and the product falling and shattering on the floor. The product in question is from Hospira, lot # LJ5801 and expiration 5/31/2027. Anyone else experiencing the same situation?

How many organizations have limited provider's ability to create personal preference lists and make modifications to order sets?

Hi my health system is reviewing storage and distribution for Creon being that the manufacture recommends storing the medication in the original bottle. I am seeking to see what work processes other institutions have done regarding properly storing, dispensing, and keeping inventory of this medication in the automated dispensing cabinets?

Hello MSOS Members,

We have very low number of ADR reporting and one of the ideas is to review naloxone use after opioid administrations during hospitalizations. Would you mind sharing how you do it (if you include naloxone in your ADR data)?

Thank you in advance for your time,

Manisa